AOCI at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's AOCI?
- Ironwood Pharmaceuticals (IRWD) reported AOCI of -$795K in Q1 2026.
- How has Ironwood Pharmaceuticals's AOCI changed year-over-year?
- Ironwood Pharmaceuticals's AOCI decreased by 370.4% year-over-year, from $294K to -$795K.
- What is the long-term trend for Ironwood Pharmaceuticals's AOCI?
- Over 2 years (2023 to 2025), Ironwood Pharmaceuticals's AOCI has grown at a -40.9% compound annual growth rate (CAGR), from -$3.03M to -$1.06M.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.